Medical Equipment

Oncology Devices Sector Forecast Shows Robust Momentum, Climbing to $397.27 Billion With 17.3% CAGR

February 9, 2026February 9, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Oncology Devices Market reach by 2030 starting from 2026 levels?

The oncology devices market size has seen rapid expansion over recent years. It is projected to expand from $177.72 billion in 2025 to $210.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.2%. The expansion during the historic period can be attributed to increasing global cancer incidence rates, the expansion of hospital oncology departments, growing demand for early diagnosis technologies, the availability of advanced imaging systems, and rising awareness of cancer screening programs.

The oncology devices market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $397.27 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.3%. This growth during the forecast period is driven by the increasing uptake of personalized cancer treatment devices, greater investments in oncology infrastructure, the expansion of outpatient cancer treatment facilities, the growing application of AI-driven diagnostic tools, and a heightened focus on precision oncology solutions. Key trends expected in this period involve the increasing embrace of advanced cancer diagnostic devices, a surge in the use of image-guided oncology therapies, the wider integration of minimally invasive cancer treatment tools, the expansion of precision radiation therapy equipment, and an enhanced emphasis on early cancer detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp

Which Drivers Are Influencing Long-Term Growth In The Oncology Devices Market?

The future expansion of the oncology devices market is anticipated to be driven by the escalating need for chemotherapy. This cancer therapy involves potent medications designed to eliminate rapidly multiplying cells, thereby impeding or halting tumor development and dissemination. The global increase in cancer cases is fueling the rise in chemotherapy demand, as a greater number of diagnoses necessitates effective and readily available treatments capable of addressing various cancer forms and progression stages. Oncology instruments enhance chemotherapy by facilitating safer and more accurate drug administration and oversight, thereby improving treatment efficacy and patient results. For example, the U.S. National Cancer Institute, a federal cancer research agency based in the U.S., forecasts that new cancer diagnoses in the United States will climb to 2.04 million in January 2025, an increase from 1.96 million in 2023. This surge underscores the growing requirement for systems that administer chemotherapy. Consequently, the heightened demand for chemotherapy is a key factor propelling the expansion of the oncology devices market.

How Is The Oncology Devices Market Divided Into Segments?

The oncology devices market covered in this report is segmented –

1) By Device Type: Brachytherapy Devices, Endoscopic Devices

2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy

3) By End User: Hospitals, Cancer Research Institutes, Other End Users

Subsegments:

1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories

2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories

Which Trends Are Expected To Influence The Oncology Devices Market In The Upcoming Years?

Major companies operating in the oncology devices market are concentrating on creating sophisticated, precision-focused solutions aimed at enhancing treatment accuracy, ensuring patient safety, and boosting clinical workflow efficiency. These innovations prominently feature minimally invasive approaches, superior visualization, and real-time therapy adjustment to achieve improved results across diverse cancer types. For instance, in April 2025, ZEISS, a Germany-based medical technology firm, secured FDA 510(k) clearance for its INTRABEAM 700 system. This platform represents a state-of-the-art robotic-assisted intraoperative radiotherapy (IORT) solution, specifically designed for precise radiation delivery during neuro-oncology and breast cancer operations. The system offers heightened precision, optimized ergonomics, and seamless integration into surgical procedures, allowing clinicians to administer localized radiation during surgery while protecting surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment planning functionalities, the INTRABEAM 700 elevates therapeutic accuracy, facilitates quicker clinical decisions, and aligns with the industry’s progression towards technologically advanced, patient-centric cancer care.

Which Major Industry Participants Are Leading The Oncology Devices Market Growth?

Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Oncology Devices Market?

North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oncology Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3373&type=smp

Browse Through More Reports Similar to the Global Oncology Devices Market 2026, By The Business Research Company

Interventional Oncology Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795